How to construct multi-factor portfolios for consistent performance
In the face of market unpredictability, structured strategies like factor investing leverage quantifiable characteristics ...
Yahoo Finance28d
Novartis Gets CHMP Opinion for Label Expansion of Fabhalta
Fabhalta is an oral, Factor B inhibitor of the alternative complement pathway 6-7. The CHMP recommended granting a marketing authorization to Fabhalta for the treatment of adults with C3 ...